Global RNAi Therapy Supply, Demand and Key Producers, 2023-2029

July 2023 | 101 pages | ID: G993F3499FDDEN
GlobalInfoResearch

Abstracts

The global RNAi Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global RNAi Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for RNAi Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNAi Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global RNAi Therapy total market, 2018-2029, (USD Million)

Global RNAi Therapy total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: RNAi Therapy total market, key domestic companies and share, (USD Million)

Global RNAi Therapy revenue by player and market share 2018-2023, (USD Million)

Global RNAi Therapy total market by Type, CAGR, 2018-2029, (USD Million)

Global RNAi Therapy total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global RNAi Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence and Sirnaomics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNAi Therapy market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global RNAi Therapy Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global RNAi Therapy Market, Segmentation by Type

• Small Molecule Interfering Ribonucleic Acid (SiRNA)
• Microrna (MiRNA)

Global RNAi Therapy Market, Segmentation by Application

• Oncology
• Cardiology
• Others

Companies Profiled:

• Alnylam
• Sarepta Therapeutics
• Alnylam Pharmaceuticals
• Moderna
• Sanofi
• Arcturus Therapeutics
• Silence
• Sirnaomics

Key Questions Answered

1. How big is the global RNAi Therapy market?

2. What is the demand of the global RNAi Therapy market?

3. What is the year over year growth of the global RNAi Therapy market?

4. What is the total value of the global RNAi Therapy market?

5. Who are the major players in the global RNAi Therapy market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 RNAi Therapy Introduction
1.2 World RNAi Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World RNAi Therapy Total Market by Region (by Headquarter Location)
  1.3.1 World RNAi Therapy Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States RNAi Therapy Market Size (2018-2029)
  1.3.3 China RNAi Therapy Market Size (2018-2029)
  1.3.4 Europe RNAi Therapy Market Size (2018-2029)
  1.3.5 Japan RNAi Therapy Market Size (2018-2029)
  1.3.6 South Korea RNAi Therapy Market Size (2018-2029)
  1.3.7 ASEAN RNAi Therapy Market Size (2018-2029)
  1.3.8 India RNAi Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 RNAi Therapy Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 RNAi Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World RNAi Therapy Consumption Value (2018-2029)
2.2 World RNAi Therapy Consumption Value by Region
  2.2.1 World RNAi Therapy Consumption Value by Region (2018-2023)
  2.2.2 World RNAi Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States RNAi Therapy Consumption Value (2018-2029)
2.4 China RNAi Therapy Consumption Value (2018-2029)
2.5 Europe RNAi Therapy Consumption Value (2018-2029)
2.6 Japan RNAi Therapy Consumption Value (2018-2029)
2.7 South Korea RNAi Therapy Consumption Value (2018-2029)
2.8 ASEAN RNAi Therapy Consumption Value (2018-2029)
2.9 India RNAi Therapy Consumption Value (2018-2029)

3 WORLD RNAI THERAPY COMPANIES COMPETITIVE ANALYSIS

3.1 World RNAi Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global RNAi Therapy Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for RNAi Therapy in 2022
  3.2.3 Global Concentration Ratios (CR8) for RNAi Therapy in 2022
3.3 RNAi Therapy Company Evaluation Quadrant
3.4 RNAi Therapy Market: Overall Company Footprint Analysis
  3.4.1 RNAi Therapy Market: Region Footprint
  3.4.2 RNAi Therapy Market: Company Product Type Footprint
  3.4.3 RNAi Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: RNAi Therapy Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: RNAi Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: RNAi Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: RNAi Therapy Consumption Value Comparison
  4.2.1 United States VS China: RNAi Therapy Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: RNAi Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based RNAi Therapy Companies and Market Share, 2018-2023
  4.3.1 United States Based RNAi Therapy Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies RNAi Therapy Revenue, (2018-2023)
4.4 China Based Companies RNAi Therapy Revenue and Market Share, 2018-2023
  4.4.1 China Based RNAi Therapy Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies RNAi Therapy Revenue, (2018-2023)
4.5 Rest of World Based RNAi Therapy Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based RNAi Therapy Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies RNAi Therapy Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World RNAi Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Small Molecule Interfering Ribonucleic Acid (SiRNA)
  5.2.2 Microrna (MiRNA)
5.3 Market Segment by Type
  5.3.1 World RNAi Therapy Market Size by Type (2018-2023)
  5.3.2 World RNAi Therapy Market Size by Type (2024-2029)
  5.3.3 World RNAi Therapy Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World RNAi Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Oncology
  6.2.2 Cardiology
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World RNAi Therapy Market Size by Application (2018-2023)
  6.3.2 World RNAi Therapy Market Size by Application (2024-2029)
  6.3.3 World RNAi Therapy Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Alnylam
  7.1.1 Alnylam Details
  7.1.2 Alnylam Major Business
  7.1.3 Alnylam RNAi Therapy Product and Services
  7.1.4 Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Alnylam Recent Developments/Updates
  7.1.6 Alnylam Competitive Strengths & Weaknesses
7.2 Sarepta Therapeutics
  7.2.1 Sarepta Therapeutics Details
  7.2.2 Sarepta Therapeutics Major Business
  7.2.3 Sarepta Therapeutics RNAi Therapy Product and Services
  7.2.4 Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Sarepta Therapeutics Recent Developments/Updates
  7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.3 Alnylam Pharmaceuticals
  7.3.1 Alnylam Pharmaceuticals Details
  7.3.2 Alnylam Pharmaceuticals Major Business
  7.3.3 Alnylam Pharmaceuticals RNAi Therapy Product and Services
  7.3.4 Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Alnylam Pharmaceuticals Recent Developments/Updates
  7.3.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Moderna
  7.4.1 Moderna Details
  7.4.2 Moderna Major Business
  7.4.3 Moderna RNAi Therapy Product and Services
  7.4.4 Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Moderna Recent Developments/Updates
  7.4.6 Moderna Competitive Strengths & Weaknesses
7.5 Sanofi
  7.5.1 Sanofi Details
  7.5.2 Sanofi Major Business
  7.5.3 Sanofi RNAi Therapy Product and Services
  7.5.4 Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Sanofi Recent Developments/Updates
  7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Arcturus Therapeutics
  7.6.1 Arcturus Therapeutics Details
  7.6.2 Arcturus Therapeutics Major Business
  7.6.3 Arcturus Therapeutics RNAi Therapy Product and Services
  7.6.4 Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Arcturus Therapeutics Recent Developments/Updates
  7.6.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
7.7 Silence
  7.7.1 Silence Details
  7.7.2 Silence Major Business
  7.7.3 Silence RNAi Therapy Product and Services
  7.7.4 Silence RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Silence Recent Developments/Updates
  7.7.6 Silence Competitive Strengths & Weaknesses
7.8 Sirnaomics
  7.8.1 Sirnaomics Details
  7.8.2 Sirnaomics Major Business
  7.8.3 Sirnaomics RNAi Therapy Product and Services
  7.8.4 Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Sirnaomics Recent Developments/Updates
  7.8.6 Sirnaomics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 RNAi Therapy Industry Chain
8.2 RNAi Therapy Upstream Analysis
8.3 RNAi Therapy Midstream Analysis
8.4 RNAi Therapy Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World RNAi Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World RNAi Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World RNAi Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World RNAi Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World RNAi Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNAi Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World RNAi Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World RNAi Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World RNAi Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key RNAi Therapy Players in 2022
Table 12. World RNAi Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global RNAi Therapy Company Evaluation Quadrant
Table 14. Head Office of Key RNAi Therapy Player
Table 15. RNAi Therapy Market: Company Product Type Footprint
Table 16. RNAi Therapy Market: Company Product Application Footprint
Table 17. RNAi Therapy Mergers & Acquisitions Activity
Table 18. United States VS China RNAi Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China RNAi Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based RNAi Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNAi Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies RNAi Therapy Revenue Market Share (2018-2023)
Table 23. China Based RNAi Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNAi Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies RNAi Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based RNAi Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNAi Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies RNAi Therapy Revenue Market Share (2018-2023)
Table 29. World RNAi Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World RNAi Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World RNAi Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World RNAi Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World RNAi Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World RNAi Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Alnylam Basic Information, Area Served and Competitors
Table 36. Alnylam Major Business
Table 37. Alnylam RNAi Therapy Product and Services
Table 38. Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Alnylam Recent Developments/Updates
Table 40. Alnylam Competitive Strengths & Weaknesses
Table 41. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 42. Sarepta Therapeutics Major Business
Table 43. Sarepta Therapeutics RNAi Therapy Product and Services
Table 44. Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Sarepta Therapeutics Recent Developments/Updates
Table 46. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 47. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Alnylam Pharmaceuticals Major Business
Table 49. Alnylam Pharmaceuticals RNAi Therapy Product and Services
Table 50. Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Alnylam Pharmaceuticals Recent Developments/Updates
Table 52. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Moderna Basic Information, Area Served and Competitors
Table 54. Moderna Major Business
Table 55. Moderna RNAi Therapy Product and Services
Table 56. Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Moderna Recent Developments/Updates
Table 58. Moderna Competitive Strengths & Weaknesses
Table 59. Sanofi Basic Information, Area Served and Competitors
Table 60. Sanofi Major Business
Table 61. Sanofi RNAi Therapy Product and Services
Table 62. Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sanofi Recent Developments/Updates
Table 64. Sanofi Competitive Strengths & Weaknesses
Table 65. Arcturus Therapeutics Basic Information, Area Served and Competitors
Table 66. Arcturus Therapeutics Major Business
Table 67. Arcturus Therapeutics RNAi Therapy Product and Services
Table 68. Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Arcturus Therapeutics Recent Developments/Updates
Table 70. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 71. Silence Basic Information, Area Served and Competitors
Table 72. Silence Major Business
Table 73. Silence RNAi Therapy Product and Services
Table 74. Silence RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Silence Recent Developments/Updates
Table 76. Sirnaomics Basic Information, Area Served and Competitors
Table 77. Sirnaomics Major Business
Table 78. Sirnaomics RNAi Therapy Product and Services
Table 79. Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of RNAi Therapy Upstream (Raw Materials)
Table 81. RNAi Therapy Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. RNAi Therapy Picture
Figure 2. World RNAi Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World RNAi Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World RNAi Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World RNAi Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company RNAi Therapy Revenue (2018-2029) & (USD Million)
Figure 13. RNAi Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World RNAi Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India RNAi Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of RNAi Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNAi Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNAi Therapy Markets in 2022
Figure 27. United States VS China: RNAi Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: RNAi Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World RNAi Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World RNAi Therapy Market Size Market Share by Type in 2022
Figure 31. Small Molecule Interfering Ribonucleic Acid (SiRNA)
Figure 32. Microrna (MiRNA)
Figure 33. World RNAi Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World RNAi Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World RNAi Therapy Market Size Market Share by Application in 2022
Figure 36. Oncology
Figure 37. Cardiology
Figure 38. Others
Figure 39. RNAi Therapy Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source